Log In
Print this Print this

P-321 ophthalmic solution

  Manage Alerts
Collapse Summary General Information
Company Parion Sciences Inc.
DescriptionEpithelial sodium channel (ENaC) inhibitor
Molecular Target Epithelial sodium channel (ENaC)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDry eye
Indication DetailsTreat dry eye disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today